Gastroenterology
Volume 135, Issue 1 , Pages 111-121, July 2008

Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan

  • Chi–Ling Chen

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine, College of Public Health, National Taiwan University, Taipei
  • ,
  • Hwai–I. Yang

      Affiliations

    • Genomics Research Center, Academia Sinica, Taipei
  • ,
  • Wei–Shiung Yang

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine, College of Public Health, National Taiwan University, Taipei
    • Department of Internal Medicine, National Taiwan University Hospital, Taipei
  • ,
  • Chun–Jen Liu

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine, College of Public Health, National Taiwan University, Taipei
    • Department of Internal Medicine, National Taiwan University Hospital, Taipei
    • Hepatitis Research Center, National Taiwan University Hospital, Taipei
  • ,
  • Pei–Jer Chen

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine, College of Public Health, National Taiwan University, Taipei
    • Department of Internal Medicine, National Taiwan University Hospital, Taipei
    • Hepatitis Research Center, National Taiwan University Hospital, Taipei
  • ,
  • San–Lin You

      Affiliations

    • Genomics Research Center, Academia Sinica, Taipei
  • ,
  • Li–Yu Wang

      Affiliations

    • Department of Public Health, Tzu-Chi University, Hualien
  • ,
  • Chien–An Sun

      Affiliations

    • School of Public Health, National Defense Medical Center, Taipei
  • ,
  • Sheng–Nan Lu

      Affiliations

    • Department of Gastroenterology, Kaohsiung Chang-Gung Memorial Hospital, Kaohsiung, Taiwan
  • ,
  • Ding–Shin Chen

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine, College of Public Health, National Taiwan University, Taipei
    • Department of Internal Medicine, National Taiwan University Hospital, Taipei
    • Hepatitis Research Center, National Taiwan University Hospital, Taipei
  • ,
  • Chien–Jen Chen

      Affiliations

    • Genomics Research Center, Academia Sinica, Taipei
    • Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei
    • Corresponding Author InformationAddress requests for reprints to: Chien-Jen Chen, ScD, Genomics Research Center, Academia Sinica, 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan.

Received 11 January 2008; accepted 27 March 2008. published online 07 April 2008.

Background & Aims: This study investigated whether obesity, diabetes, and other metabolic factors are independently associated with hepatocellular carcinoma (HCC), stratified by hepatitis B virus (HBV) and hepatitis C virus (HCV) serostatus, and explored the possible joint influence of obesity/diabetes and HBV/HCV infections on the risk of HCC. Methods: A total of 23,820 residents in Taiwan were recruited and followed up for 14 years. All analyses were stratified by hepatitis B surface antigen (HBsAg) and antibody to HCV (anti-HCV) at enrollment, and 218 subjects positive for both seromarkers were excluded. Incident HCC cases were identified via linkage to the national cancer registry. Multivariate-adjusted relative risk (RRa) and 95% confidence interval (95% CI) were estimated using Cox proportional hazards models. Results: Extreme obesity (body mass index ≥30 kg/m2) was independently associated with a 4-fold risk of HCC (RRa, 4.13; 95% CI, 1.38–12.4) among anti-HCV–seropositive subjects and a 2-fold risk (RRa, 2.36; 95% CI, 0.91–6.17) in persons without HBV and HCV infections, after controlling for other metabolic components, but not in HBsAg-seropositive subjects (RRa, 1.36; 95% CI, 0.64–2.89). Diabetes was associated with HCC in all 3 groups, with the highest risk in those with HCV infection (RRa, 3.52; 95% CI, 1.29–9.24) and lowest in HBV carriers (RRa, 2.27; 95% CI, 1.10–4.66). We found more than 100-fold increased risk in HBV or HCV carriers with both obesity and diabetes, indicating synergistic effects of metabolic factors and hepatitis. Conclusions: The finding that both obesity and diabetes are predictors of HCC risk, possibly differently depending on HBV and HCV infection status, may shed some light in preventing HCC.

Abbreviations used in this paper: BMI, body mass index, CI, confidence interval, EF, etiologic fraction, RR, relative risk, TG, triglyceride, VLDL, very-low-density lipoprotein

 

 Supported by grant NSC-94-2314-B002-268 from the National Science Council and Department of Health, Executive Yuan, Taiwan.

 The authors report that no conflicts of interest exist.

PII: S0016-5085(08)00569-6

doi:10.1053/j.gastro.2008.03.073

Refers to article:

  • Continuing Medical Education Exam 2: July 2008 , 12 June 2008

    Gastroenterology July 2008 (Vol. 135, Issue 1, Page 293)

Gastroenterology
Volume 135, Issue 1 , Pages 111-121, July 2008